Physician
Community Healthcare Partner, INC
Community Healthcare Partner, INC was paid $2.44M by Medicaid between Jan 2018 and Nov 2024, across 92 billing codes. Its largest line is 99283, emergency room visit (moderate) — 26% of everything it billed.
33Billing provider infoCOMMUNITY HEALTHCARE PARTNER, INC
NEEDLES, CA 92363
NEEDLES, CA 92363
33aNPI1457520942assigned 02/28/2008
33bProvider typeEmergency Medical Services (Emergency Medicine) Physician
28Total paid$2.44M
24GClaims111,470
24DCodes billed92
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Emergency Medical Services (Emergency Medicine) Physician providers in California
Rank by total paid#10 of 43
Median peer was paid$29K
This provider vs. median84×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 12,277 | $260K | |
| 2019 | 12,663 | $247K | |
| 2020 | 12,140 | $235K | |
| 2021 | 11,089 | $210K | |
| 2022 | 19,648 | $460K | |
| 2023 | 23,538 | $531K | |
| 2024incomplete | 20,115 | $497K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 26% | 13,183 | 12,133 | $624K |
| Z7502 | 8.8% | 5,883 | 5,606 | $215K | |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 8.7% | 3,648 | 3,456 | $213K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 5.7% | 1,625 | 1,525 | $138K |
| 80053 | Comprehensive metabolic panel | 4.6% | 10,679 | 9,313 | $113K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 4.0% | 4,015 | 3,854 | $99K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 3.8% | 997 | 951 | $93K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.2% | 9,789 | 8,689 | $78K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 2.9% | 1,281 | 762 | $70K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.2% | 3,044 | 2,561 | $54K |
| 70450 | Computed tomography, head or brain; without contrast material | 2.0% | 401 | 395 | $49K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1.7% | 1,632 | 1,564 | $43K |
80 more codes
| Z7610 | 1.6% | 3,346 | $39K | |
| 0450 | Emergency room services | 1.5% | 823 | $37K |
| 86710 | 1.5% | 2,144 | $37K | |
| 71250 | 1.4% | 233 | $34K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.3% | 1,617 | $31K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 1.2% | 3,405 | $30K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.1% | 832 | $28K |
| 80061 | Lipid panel | 1.1% | 1,604 | $28K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.1% | 1,119 | $27K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.1% | 891 | $27K |
| 87430 | <1% | 1,565 | $19K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 266 | $17K |
| 82553 | <1% | 1,523 | $17K | |
| 84484 | <1% | 1,683 | $16K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 748 | $16K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 628 | $16K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 263 | $15K |
| 99499 | <1% | 339 | $15K | |
| 99070 | <1% | 3,650 | $15K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 994 | $14K |
| 83880 | <1% | 731 | $13K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 233 | $11K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 887 | $11K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,558 | $11K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 699 | $10K |
| 81001 | <1% | 3,117 | $10K | |
| 82550 | <1% | 2,038 | $9K | |
| 84439 | <1% | 692 | $8K | |
| 81025 | <1% | 1,268 | $8K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 2,089 | $8K |
| 83690 | <1% | 712 | $6K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 125 | $5K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,040 | $5K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 29 | $5K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 326 | $5K |
| 85379 | <1% | 375 | $4K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,135 | $4K |
| 82150 | <1% | 439 | $4K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 105 | $3K |
| 87088 | <1% | 564 | $3K | |
| 84481 | <1% | 161 | $3K | |
| 85730 | <1% | 421 | $3K | |
| J3490 | Unclassified drugs | <1% | 1,527 | $2K |
| 82746 | <1% | 132 | $2K | |
| 85610 | <1% | 447 | $2K | |
| 87040 | <1% | 151 | $2K | |
| 82607 | <1% | 84 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 41 | $1K |
| 83735 | <1% | 207 | $1K | |
| Z7504 | <1% | 29 | $1K | |
| J3370 | Injection, vancomycin hcl, 500 mg | <1% | 115 | $1K |
| 80305 | <1% | 167 | $1K | |
| 83605 | <1% | 107 | $1K | |
| 96367 | <1% | 24 | $811.72 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 151 | $767.73 |
| 87186 | <1% | 84 | $737.42 | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 22 | $733.89 |
| 73630 | <1% | 37 | $688.97 | |
| 71020 | <1% | 25 | $609.69 | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 16 | $592.95 |
| 87807 | <1% | 71 | $580.61 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 182 | $540.90 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 12 | $509.68 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 809 | $498.07 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | <1% | 81 | $468.78 |
| 84436 | <1% | 39 | $421.33 | |
| 87077 | <1% | 99 | $320.31 | |
| 86703 | <1% | 14 | $232.31 | |
| 73130 | <1% | 12 | $226.74 | |
| 0270 | <1% | 213 | $224.88 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,359 | $184.45 |
| 87899 | <1% | 14 | $184.42 | |
| 82977 | <1% | 36 | $155.28 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 20 | $73.48 |
| 82043 | <1% | 13 | $52.40 | |
| S0164 | Injection, pantoprazole sodium, 40 mg | <1% | 12 | $51.68 |
| 0250 | <1% | 51 | $32.38 | |
| 0250R | 0% | 215 | $0.00 | |
| 0272R | 0% | 147 | $0.00 | |
| 0270R | 0% | 111 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLOPEZ, STEVE (CEO)